Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Over the £25 today, just like I said they would be.
And yes, I've been trading in Greggs shares for year's and done extremely well during that time.
To think they've been well over £30 and there's absolutely no reason with the current expansion to foreign shores and tie up with Just Eat they won't be there again.
@Halma
You said you had sold your Greggs shares at around £23 a share even though you said you you bought at £24.
Correct me if I am wrong have you posted on here that you bought back in Greggs? Or are you just the idiot I think you are and sold too soon.
@Max
I told you about trading good companies like Greggs and thanks for the encouraging tip when they dropped back
You laughed and joked, poked fun at the price but as said
They have a long proven track record and will easily see £25 or more in the near future.
Back over £24 quid I see, didn't take long, a hell of a lot faster than BRH will take to get back to 15 pence.
You trade in pebbles and boast about it, time to step up and invest some real money in real companies!
On what information do you base this on? Is this just wishful thinking on your part?
Poor old Halma banging on about fire works again. We are talking about the Share price dummy !!
The only rocket you'd know about is a firework
I'm hopeful for this year ,,, sepsis and covid gaining strength 🍷
Castle
Castle
He left before but was still very much pulling all the strings
Then returned to shorten them further
I feel if there is a sale of any kind, the proceeds will be divided between the shareholders in the from of a dividend, don’t forget TB is not getting any younger and had already delayed his planned retirement was delayed, he wants out.
Professor Carl Smythe
School of Biosciences
Professor of Cell Biology
Director of the Mass Spectrometry Centre
VS
Who exactly ?
Why ?
Who's the doctor or specialist? I think that the asset CX300 is likely to be winner in my opinion but let the medical sciences speak, we await RNS, when all test are done. Otherwise we are simizing!!
Has we all know, early detection of all infections/diseases is critical to cure and the monetary benefits for the NHS are huge.
D68 , thank you for sharing your knowledge, but it’s totally pointless having such a huge list of checks to stop the thousands of unnecessary patient deaths, if there is not enough nurses and doctors and systems in place to carry out these procedures/check’s/evaluations.
So i’m sure you will agree that if any piece of testing equipment with an high percentage accuracy of pinpointing the patient’s that are most at risk, allowing the correct treatment to stop their immune system over-reacting with blood disorders causing organ failure/death, then it must be worthy of help from government.
One day Rodney you could be that patient (not a millionaire). This is just my way looking at one of the largest killers in the world, please no abuse, thank you. X
Darwen
Thank you for the very detailed medical analysis. It is good to get additional info regarding how sepsis is actually diagnosed so we can see the true worth of our technology.
Thanks
How to kill a werewolf part 1 lol
All If's and but's, someone needs to step up to the plate and reassure shareholders there's going to be something at the end of the rainbow.
This would be a very wise move if further investment is to be forthcoming
The board talk/hope that the "sepsis screen" will revolutionise sepsis management.
I write as an investor rather than a trader where the following has no relevance.
When a patient presents with a possible sepsis or infection there is already many applications/algorithms available to help in a diagnosis.
Observations of heart rate,pulse,BP,O2 saturation and temperature.
Then there is blood gas analysis which will give pH,pCO2,pO2 and very likely lactate analysis giving indication of acidosis.
In addition to this there is further tests that can be carried out full blood count (especially white cells),crp,lactate,procalcitonin,blood cultures and swabs.
Paraytec,as of the last RNS,has an unproven,still in development method of detecting possible sepsis.Even if proved up,the use of the test will be in addition to all of the above and not a sweeping replacement.
Most disease is diagnosed using a jigsaw of information.
Better sepsis diagnosis is important but will never be confirmed using just the one parameter.In this day and age, deciding to treat/ not treat on that basis would be a litigation nightmare.
So,a silver bullet - no,but a useful tool - hopefully.
A long long way to go to gain a proven method with medical accreditation,and then you have to sell it into the marketplace.
Does anyone know of any similar testing products that have been bought outright by a big pharma,
Cizzle Biotech have a similar test, but for lung disease and i think they also can’t go it alone.
Richie.
It has to get bought up by big pharma or in reality and more nuanced,big analytica.
Paraytec would not be able to compete,market,implement globally or in the internal markets that it so desires on any scalability, due to Paraytec size in the field.
What ever happened to the 70+ interested parties?.
In my opinion this is locked loaded and ready to fire
I will ask again.
Apart from a dividend from P2F sale to RMS what has the investment company BRH/TB had success with.
Paraytec was kicked into the long grass on the latest RNS as further as yet more development is needed.Phasefocus and Kirstall have mean promoted for sale for a number of years with no takers as of yet.
Good morning Olwi
Yes I think it's achievable + Dividend
I bought some at £1.20
BRH has a lot going for it being a investment company and even though TB is past retirement and in not liked for being cunning and roofless he is a brilliant business and gets things done !! the man and wants to go out with a bang CX300
Castle
We've had a rise to 1.20 before and at that time it was mostly substantial news.
Now we're are in a position were BRH can licence or sell CE marked products. At the end of the day nothing is promised but I definitely see the potential to achieve over the pound mark but, as always it down to the board who need to deliver for the VERY PATIENT and FRUSTATED shareholders.